Published in Acta Naturae on July 01, 2010
Gums and mucilages. Adv Carbohydr Chem Biochem (1969) 2.80
Ganoderma - a therapeutic fungal biofactory. Phytochemistry (2006) 1.93
The chemical structure of bacterial endotoxin in relation to bioactivity. Immunobiology (1993) 1.69
Palytoxin: a new marine toxin from a coelenterate. Science (1971) 1.56
Medicinal importance of fungal beta-(1-->3), (1-->6)-glucans. Mycol Res (2007) 1.55
Fractionation and purification of the polysaccharides with marked antitumor activity, especially lentinan, from Lentinus edodes (Berk.) Sing. (an edible mushroom). Cancer Res (1970) 1.54
Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy. Cancer Epidemiol Biomarkers Prev (2001) 1.43
Study of the antigenic structure of tumors. Acta Unio Int Contra Cancrum (1963) 1.29
Immunomodulating and anticancer agents in the realm of macromycetes fungi (macrofungi). Int Immunopharmacol (2007) 1.28
Anti-tumor and immunoregulatory activities of Ganoderma lucidum and its possible mechanisms. Acta Pharmacol Sin (2004) 1.25
Apoptosis in prostate carcinogenesis. A growth regulator and a therapeutic target. Cell Tissue Res (2000) 1.23
[Structure of lipopolysaccharides from gram-negative bacteria. III. Structure of O-specific polysaccharides]. Biokhimiia (1994) 1.17
Some chemical properties of maitotoxin, a putative calcium channel agonist isolated from a marine dinoflagellate. J Biochem (1988) 1.05
Antimicrobial activity of a compound isolated from an oil-macerated garlic extract. Biosci Biotechnol Biochem (1998) 1.02
Chemical components and molecular mass of six polysaccharides isolated from the sclerotium of Poria cocos. Carbohydr Res (2004) 1.00
A review of physical activity and prostate cancer risk. Cancer Causes Control (2001) 1.00
Structural and immunological studies of a major polysaccharide from spores of Ganoderma lucidum (Fr.) Karst. Carbohydr Res (2001) 0.95
Toxicological evaluation of palytoxin in several animal species. Toxicon (1974) 0.92
Purification, characterization, and modification of T lymphocyte-stimulating polysaccharide from spores of Ganoderma lucidum. Chem Pharm Bull (Tokyo) (2002) 0.87
Antiandrogens in prostate cancer. Invest New Drugs (1999) 0.86
Androgens and prostate cancer. World J Urol (2003) 0.84
Garlic (Allium sativum) extract inhibits lipopolysaccharide-induced Toll-like receptor 4 dimerization. Biosci Biotechnol Biochem (2008) 0.84
Occurrence of a food poisoning incident by palytoxin from a serranid Epinephelus sp. in Japan. J Nat Toxins (2002) 0.84
Chemical and immunochemical studies on Pasteurella pseudotuberculosis lipopolysaccharides. I. Isolation and general characterization. Immunochemistry (1971) 0.81
[CURRENT DATA ON EMBRYO-SPECIFIC ANTIGENIC COMPONENTS IN THE HUMAN BLOOD SERUM]. Vopr Med Khim (1965) 0.81
A new antitumor polysaccharide from the mycelia of Poria cocos wolf. Chem Pharm Bull (Tokyo) (1983) 0.81
[Polysaccharides of flower plants: structure and physiological activity]. Bioorg Khim (1998) 0.81
Immuno-potentiating effects of the antler-shaped fruiting body of Ganoderma lucidum (Rokkaku-Reishi). Biosci Biotechnol Biochem (2004) 0.80
[Lipopolysaccharide-protein complexes of the outer membrane of gram-negative bacteria]. Bioorg Khim (1983) 0.80
A retrospective and prospective overview of prostate-specific antigen. J Cancer Res Clin Oncol (1997) 0.80
Structure and chain conformation of five water-soluble derivatives of a beta-D-glucan isolated from Ganoderma lucidum. Carbohydr Res (2008) 0.80
Anti-tumor activities of the antlered form of Ganoderma lucidum in allogeneic and syngeneic tumor-bearing mice. Biosci Biotechnol Biochem (2006) 0.80
Highly oxygenated lanostane triterpenoids from the fungus Ganoderma applanatum. Chem Pharm Bull (Tokyo) (2008) 0.78
Hormone refractory prostate cancer: Management and advances. Cancer Treat Rev (2006) 0.78
Thermostability of allicin determined by chemical and biological assays. Biosci Biotechnol Biochem (2008) 0.78
[Prostate cancer: evolution of approach]. Vopr Onkol (2009) 0.77
[Metabolic fingerprinting of blood plasma for patients with prostate cancer]. Biomed Khim (2009) 0.77
Carcinoembryonic antigen, its spatial structure and localization of antigenic determinants. Tumour Biol (1990) 0.77
[Inhibition of neutrophil adhesion by pectic galacturonans]. Bioorg Khim (2007) 0.76
Coumarins from campylotropis hirtella (FRANCH.) SCHINDL. and their inhibitory activity on prostate specific antigen secreted from LNCaP cells. Chem Pharm Bull (Tokyo) (2008) 0.76
[Somatostatin analogs in the combined treatment of patients with hormone-resistant prostate cancer]. Vopr Onkol (2009) 0.76
[Palliative therapy of locally-advanced prostate cancer following radical treatment]. Vopr Onkol (2009) 0.76
[Bioorganic chemistry: institutes, journals, publications, a short scientific metric analysis. On the 50th anniversary of the Institute of Natural Compound Chemistry, Institute of Bioorganic Chemistry]. Bioorg Khim (2009) 0.76
[Current information about pectin substances]. Bioorg Khim (2009) 0.76
[Development of a rapid method for the detection of prostate-specific antigen by immunochromatography]. Bioorg Khim (2007) 0.76
Variations in embryospecific globulins of human blood sera in foetuses and the newborn. Nature (1968) 0.76
New lanostane triterpene lactones from the Vietnamese mushroom Ganoderma colossum (FR.) C. F. BAKER. Chem Pharm Bull (Tokyo) (2008) 0.76
[Enzyme composition of the lysosomes of Aspergillus clavatus]. Mikrobiologiia (1977) 0.76
[Quality of life of patients with locally-advanced prostate cancer as a criterium of therapeutic effectiveness]. Vopr Onkol (2009) 0.76
[Immunochemical and molecular-genetic markers in gastric cancer diagnostics]. Biomed Khim (2009) 0.75